Straube Richard 4
4 · SOLIGENIX, INC. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
Straube Richard
Sr VP & Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2021-12-09+40,000→ 40,000 totalExercise: $0.78From: 2021-12-09Exp: 2031-12-08→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 9, 2021.